Drug interactions
Rituximab-hyaluronidase + Siponimod
Severity: Major
Rituximab-hyaluronidase and Siponimod: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Rituximab depletes B cells and siponimod reduces lymphocyte circulation, so combining them can deepen immunosuppression. The risk of serious infection may persist for months after rituximab because of its prolonged effect on B cells.
What this interaction means in plain words
Rituximab-hyaluronidase and Siponimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Why it happens
Additive pharmacodynamic immunosuppression from CD20-mediated B-cell depletion and S1P receptor-mediated lymphocyte sequestration.
What to do
Avoid starting siponimod while the effects of recent rituximab persist. Monitor lymphocyte counts and watch closely for infection, including opportunistic infection.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Rituximab-hyaluronidase and Siponimod, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Siponimod
- Cladribine + Siponimod Contraindicated
- Fingolimod + Siponimod Contraindicated
- Fluconazole + Siponimod Contraindicated
- Influenza virus vaccine quadrivalent intranasal + Siponimod Contraindicated
- Ponesimod + Siponimod Contraindicated
- Siponimod + Thioridazine Contraindicated
Frequently asked questions
Can I take Rituximab-hyaluronidase with Siponimod?
MediHelp rates the interaction as major. Rituximab-hyaluronidase and Siponimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Rituximab depletes B cells and siponimod reduces lymphocyte circulation, so combining them can deepen immunosuppression. The risk of serious infection may persist for months after rituximab because of its prolonged effect on B cells.
How serious is the interaction between Rituximab-hyaluronidase and Siponimod?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid starting siponimod while the effects of recent rituximab persist. Monitor lymphocyte counts and watch closely for infection, including opportunistic infection.
What other medicines interact with Siponimod?
MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
